|
|
- 2018
Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?DOI: 10.2174/1874192401812010029 Keywords: LDL-C, Inflammation, Cardiovascular events, Statins, Ezetimibe, PCSK9 inhibitors Abstract: Low density lipoprotein cholesterol (LDL-C) and low grade arterial inflammation are key pathogenic factors for atherosclerosis and its manifestation, cardiovascular disease (CVD)
|
